(Q80534813)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351914%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

From the magic bullet to an effective therapy: the peptide experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351914%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351914%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

4 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351914%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

number of pages

6

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351914%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351914%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351914%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1393-1398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351914%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-004-1661-3

1 January 2020

exact match

0 references

cites work

Intraoperative detection of lung cancer by octreotide labeled to Indium-111

1 reference

12 December 2020

Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model

1 reference

12 December 2020

Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours

1 reference

12 December 2020

Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours

1 reference

12 December 2020

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings

1 reference

12 December 2020

Translational research using the sodium/iodide symporter in imaging and therapy

1 reference

12 December 2020

99mTc-N4-[Tyr3]Octreotate Versus 99mTc-EDDA/HYNIC-[Tyr3]Octreotide: an intrapatient comparison of two novel Technetium-99m labeled tracers for somatostatin receptor scintigraphy.

1 reference

12 December 2020

PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide.

1 reference

12 December 2020

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

1 reference

12 December 2020

Radionuclide therapy in oncology: the dawning of its concomitant use with other modalities?

1 reference

12 December 2020

Indium-111 octreotide in Graves' disease and in the evaluation of active exophthalmos

1 reference

12 December 2020

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

1 reference

12 December 2020

A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors

1 reference

12 December 2020

Evaluation of Positron Emission Tomography Imaging Using [68Ga]-DOTA-D Phe1-Tyr3-Octreotide in Comparison to [111In]-DTPAOC SPECT. First Results in Patients with Neuroendocrine Tumors

1 reference

12 December 2020

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

1 reference

12 December 2020

86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion

1 reference

12 December 2020

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

1 reference

12 December 2020

110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET.

1 reference

12 December 2020

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

12 December 2020

[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy

1 reference

12 December 2020

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

12 December 2020

High expression of peptide receptors as a novel target in gastrointestinal stromal tumours

1 reference

12 December 2020

A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours

1 reference

12 December 2020

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

1 reference

12 December 2020

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine

1 reference

12 December 2020

The biological approach to radioimmunoscintigraphy

1 reference

12 December 2020

10.1007/S00259-004-1661-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15351914%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference